Αρχειοθήκη ιστολογίου

Παρασκευή 19 Ιανουαρίου 2018

Aprepitant did not modify global disease activity in cutaneous T cell lymphomas

Abstract

Recent investigations are focused on the potential antitumor effect of neurokinin-1 receptor (NK1R) antagonists in different neoplastic diseases1. Consequently, Kwatra et al. raised an interesting observation about the possible influence of aprepitant on CTCL outcome2.

This article is protected by copyright. All rights reserved.



from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2mVTVqK

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου